LifeVantage (LFVN) director Darwin Lewis buys 3,955 shares at $5.22

Rhea-AI Filing Summary

LifeVantage director Darwin Lewis bought 3,955 shares of company common stock in an open‑market transaction at a weighted average price of $5.2216 per share. After this purchase on February 9, 2026, he directly owns 135,508 LifeVantage shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lewis Darwin

(Last) (First) (Middle)

3300 TRIUMPH BLVD, SUITE 700

(Street)

LEHI UT 84043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		P		3,955	A	$5.2216(1)	135,508	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.02 to $5.255, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Alissa Neufeld, Power of Attorney for Darwin Lewis	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did LifeVantage (LFVN) director Darwin Lewis report?

Director Darwin Lewis reported buying 3,955 shares of LifeVantage common stock in an open‑market transaction. The purchase used a weighted average price of $5.2216 per share, reflecting multiple trades within a narrow intraday price range.

At what price did Darwin Lewis buy LifeVantage (LFVN) shares?

Lewis reported a weighted average purchase price of $5.2216 per share. According to the filing footnote, the individual trades were executed between $5.02 and $5.255 per share, inclusive, across multiple transactions on the same trading day.

How many LifeVantage (LFVN) shares does Darwin Lewis own after this transaction?

Following the reported purchase, Darwin Lewis directly owns 135,508 shares of LifeVantage common stock. This total reflects his holdings after adding the newly acquired 3,955 shares bought in the open‑market transaction on February 9, 2026.

Was the LifeVantage (LFVN) director’s purchase a direct or indirect holding?

The filing shows Lewis’s ownership as direct, coded “D” in the ownership column. No indirect holding entity, such as a trust or partnership, is indicated, and the nature of ownership field is left blank in the reported transaction.

What does the weighted average price mean in the LifeVantage (LFVN) Form 4?

The weighted average price of $5.2216 reflects several individual trades executed between $5.02 and $5.255 per share. The director notes he can provide detailed trade‑level pricing information to the company, any shareholder, or SEC staff upon request.

When did the LifeVantage (LFVN) insider share purchase occur?

The open‑market purchase by director Darwin Lewis occurred on February 9, 2026. All 3,955 LifeVantage common shares reported in the Form 4 were acquired on that date, as shown in the transaction date column for the non‑derivative securities table.